Physician
Pathology
Dr. Mary E. Edgerton, MD
|
|
Give Review
Mary Edgerton works in the field of Pathology. Doctor Mary E. Edgerton, MD is a published doctor. She published 23 publications, including: '2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer Center.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- 2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer Center.
- The Cancer Genome Atlas Pan-Cancer analysis project.
- A novel, patient-specific mathematical pathology approach for assessment of surgical volume: Application to ductal carcinoma in situ of the breast.
- Copy Number Imbalances Between Screen and Symptom-Detected Breast Cancers and Impact on Disease-free Survival.
- Multiplicity: an organizing principle for cancers and somatic mutations.
- Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.
- Is it too soon to start reporting HER2 genetic heterogeneity?
- Prediction of drug response in breast cancer using integrative experimental/computational modeling.
- Ductal carcinoma in situ: state of the science and roadmap to advance the field.
- Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
- Using prior knowledge and rule induction methods to discover molecular markers of prognosis in lung cancer.
- Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.
- Significance of p63 amplification and overexpression in lung cancer development and prognosis.
- The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes.
- A standards based ontological approach to information handling for use by organizations providing human tissue for research.
- The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data.
- A bioinformatics tool to select sequences for microarray studies of mouse models of oncogenesis.
- Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family.
- Data mining for gene networks relevant to poor prognosis in lung cancer via backward-chaining rule induction.
- Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma.
- Bagged gene shaving for the robust clustering of high-throughput data.
- The deployment of a tissue request tracking system for the CHTN: a case study in managing change in informatics for biobanking operations.
Schools
Med Coll Of Pa
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Pennsylvania Health System
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699790766 |
| Last Name Of The Provider | EDGERTON |
| First Name Of The Provider | MARY |
| View All |
Similar Doctors
|
|
Dr. Mary V. Gresik, MD
 This Doctor is OpenDoctor Recommended.
|